Scientific Presentations + Publications

Scientific Presentations + Publications

Automatic Population of the Case Report Forms for an International Multifactorial Adaptive Platform Trial Amid the COVID-19 Pandemic

MAY 31, 2024

AMIA JT SUMMITS TRANSL SCI PROC.

Intravenous Vitamin C for Patients Hospitalized With COVID-19
Two Harmonized Randomized Clinical Trials

OCTOBER 25, 2023

JAMA

Simvastatin in Critically Ill Patients with Covid-19

OCTOBER 25, 2023

NEJM

Continuation of therapeutic dose heparin for critically ill patients with COVID-19

MAY 31, 2023

SPRINGERLINK

Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19A Randomized Clinical Trial

APRIL 11, 2023

JAMA

Long-term(180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial

DECEMBER 16, 2022

JAMA

Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19

JANUARY 18, 2022

JAMA

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

AUGUST 4, 2021

NEJM

Adaptive Platform Trials: The Clinical Trial of the Future? (C)

JULY 2021

ARIEL D. STERN AND SARAH MEHTA, HARVARD BUSINESS REVIEW

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

FEBRUARY 25, 2021

NEJM

Implementation of the Randomized Embedded Multifactorial Adaptive Platform for COVID-19 (REMAP-COVID) trial in a US health system—lessons learned and recommendations

JANUARY 28, 2021

BIOMED CENTRAL

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19. The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial

SEPTEMBER 2, 2020

JAMA

Adaptive Platform Trials: The Clinical Trial of the Future? (B)

SEPTEMBER 2019

ARIEL D. STERN AND SARAH MEHTA, HARVARD BUSINESS REVIEW

Adaptive Platform Trials: Definition, Design, Conduct and Reporting Considerations

AUGUST 28, 2019

NATURE REVIEWS DRUG DISCOVERY

Adaptive Platform Trials: The Clinical Trial of the Future?

SEPTEMBER 26, 2017

ARIEL D. STERN AND SARAH MEHTA, HARVARD BUSINESS REVIEW

Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE

SEPTEMBER 20, 2017

DR. BRIAN M. ALEXANDER, DR. SUJUAN BA, DR. WEBSTER CAVENEE, DR. TIMOTHY F. CLOUGHESY, DR. W.K. ALFRED YUNG – AMERICAN ASSOCIATION FOR CANCER RESEARCH

CURRENT COLLABORATIONS + INITIATIVES